Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics
|
December 4, 2019
Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients
Patrick C Flannery, Kodye L Abbott, Satyanarayana R Pondugula
ACS Chemical Neuroscience
|
November 24, 2020
Dysregulation of Endobiotic Homeostasis Mechanisms: Novel Insights into Adverse Pharmacokinetic Interactions between Illicit Substances and Clinical Drugs
Julia M Salamat, Kodye L Abbott, Patrick C Flannery, et al.
ACS Omega
|
April 6, 2022
Interplay between the Cannabinoid System and microRNAs in Cancer
Julia M Salamat, Kodye L Abbott, Patrick C Flannery, et al.
ACS Chemical Neuroscience
|
May 13, 2020
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances
Kodye L Abbott, Kristina S Gill, Patrick C Flannery, et al.
Toxicology Letters
|
December 28, 2014
Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR
Satyanarayana R Pondugula, Patrick C Flannery, Kodye L Abbott, et al.
Drug Metabolism Reviews
|
December 13, 2019
Adverse pharmacokinetic interactions between illicit substances and clinical drugs
Kodye L Abbott, Patrick C Flannery, Kristina S Gill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 7, 2015
Mg2+/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression
Satyanarayana R Pondugula, Patrick C Flannery, Udayan Apte, et al.
ACS Omega
|
October 3, 2022
Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes
Kodye L Abbott, Julia M Salamat, Patrick C Flannery, et al.
Cancer Letters
|
March 26, 2016
Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells
Chandrabose Karthikeyan, Ritu Malla, Charles R Ashby, et al.
Oncology Reports
|
December 6, 2017
Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma
Patrick C Flannery, John A DeSisto, Vladimir Amani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Journal of Drug Metabolism and Pharmacokinetics
|
December 4, 2019
Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients
Patrick C Flannery, Kodye L Abbott, Satyanarayana R Pondugula
ACS Chemical Neuroscience
|
November 24, 2020
Dysregulation of Endobiotic Homeostasis Mechanisms: Novel Insights into Adverse Pharmacokinetic Interactions between Illicit Substances and Clinical Drugs
Julia M Salamat, Kodye L Abbott, Patrick C Flannery, et al.
ACS Omega
|
April 6, 2022
Interplay between the Cannabinoid System and microRNAs in Cancer
Julia M Salamat, Kodye L Abbott, Patrick C Flannery, et al.
ACS Chemical Neuroscience
|
May 13, 2020
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances
Kodye L Abbott, Kristina S Gill, Patrick C Flannery, et al.
Toxicology Letters
|
December 28, 2014
Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR
Satyanarayana R Pondugula, Patrick C Flannery, Kodye L Abbott, et al.
Drug Metabolism Reviews
|
December 13, 2019
Adverse pharmacokinetic interactions between illicit substances and clinical drugs
Kodye L Abbott, Patrick C Flannery, Kristina S Gill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 7, 2015
Mg2+/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression
Satyanarayana R Pondugula, Patrick C Flannery, Udayan Apte, et al.
ACS Omega
|
October 3, 2022
Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes
Kodye L Abbott, Julia M Salamat, Patrick C Flannery, et al.
Cancer Letters
|
March 26, 2016
Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells
Chandrabose Karthikeyan, Ritu Malla, Charles R Ashby, et al.
Oncology Reports
|
December 6, 2017
Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma
Patrick C Flannery, John A DeSisto, Vladimir Amani, et al.
Page
of 2